Literature DB >> 6128443

Pituitary proliferative lesions in aging male Long-Evans rats. A model of mixed multiple endocrine neoplasia syndrome.

A K Lee, R A DeLellis, M Blount, G Nunnemacher, H J Wolfe.   

Abstract

The incidence of spontaneous pituitary nodules in rats increases progressively with age. In a colony of male Long-Evans rats, 50 per cent of the 2- to 3-year-old animals harbored pituitary nodules which were composed almost exclusively of sparsely granulated prolactin (PRL) cells. Sixty per cent of the PRL nodules were multicentric and in most instances were associated with diffuse hyperplasia of PRL cells adjacent to the nodules. A progressive increase with age in the population of PRL cells was also observed. These findings suggest that the pituitary nodules may have originated from foci of PRL hyperplasia. Furthermore, five of these glands contained additional nodules of other hormonal cell types, including mixed PRL/gonadotropins (two animals), mixed PRL/thyrotropin-stimulating hormone (one), gonadotropins (one), and adrenocorticotropic hormone (one). These animals also demonstrated a high incidence of thyroidal C cell nodular hyperplasia and/or medullary thyroid carcinoma (42 per cent), adrenal medullar nodules (31 per cent), and parathyroid nodular hyperplasia (30 per cent). In human kindreds with multiple endocrine neoplasia syndromes, concomitant thyroidal C cell and adrenal medullary proliferative lesions, as well as parathyroid abnormalities, are found in type II phenotype patients, whereas pituitary, pancreatic islet, and parathyroid abnormalities develop in patients with type I phenotype. The Long-Evans rat strain, with concomitant proliferative lesions in these four endocrine organs, may provide a useful model system of a mixed multiple endocrine neoplasia syndrome and, also, of prolactin-secreting pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128443

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

Review 1.  Multiple endocrine neoplasia type I: general features and new insights into etiology.

Authors:  M L Brandi
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

Review 2.  Acid suppression and gastric mucosal cell biology.

Authors:  G Delle Fave; H Helander; S Holt; I M Modlin; R Powers; E Solcia; A Soll; Y Tielemans; N A Wright
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 3.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System.

Authors:  Annamaria Brändli-Baiocco; Emmanuelle Balme; Marc Bruder; Sundeep Chandra; Juergen Hellmann; Mark J Hoenerhoff; Takahito Kambara; Christian Landes; Barbara Lenz; Mark Mense; Susanne Rittinghausen; Hiroshi Satoh; Frédéric Schorsch; Frank Seeliger; Takuji Tanaka; Minoru Tsuchitani; Zbigniew Wojcinski; Thomas J Rosol
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

Review 4.  Molecular basis of pituitary oncogenesis.

Authors:  M Tada; H Kobayashi; T Moriuchi
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.

Authors:  R V Lloyd
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

6.  Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.

Authors:  D J McComb; P Hellmann; M O Thorner; D Scott; W S Evans; K Kovacs
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

Review 7.  Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.

Authors:  J W Freston; K Borch; S J Brand; E Carlsson; W Creutzfeldt; R Håkanson; L Olbe; E Solcia; J H Walsh; M M Wolfe
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Adrenergic differentiation and Ret expression in rat pheochromocytomas.

Authors:  James F Powers; Kristen L Picard; Abraham Nyska; Arthur S Tischler
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 9.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 10.  The consequences of hypergastrinemia.

Authors:  W Creutzfeldt
Journal:  Yale J Biol Med       Date:  1994 May-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.